Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck’s ‘COVID Pill’ Shows Promise, But Mortality Benefits Will Be Hard To Prove
Accurate Viral Test Shows Drug’s Promise
Mar 08 2021
•
By
Andrew McConaghie
A pulse oximeter has become standard at-home technology for people ill with COVID-19 - but there is still no medicine which can be taken in this setting to speed recovery.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip